Jon Snodgres - 14 May 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Reporting relationship: Chief Financial Officer
Issuer ticker: RGEN
Reported as of: 14 May 2021
Net transaction value: -$81,122
SEC form: 4
Accepted by SEC: 18 May 2021, 07:49:02 UTC
Next SEC filing: 22 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Brown (Attorney in Fact)

Key filing fact

Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 18 May 2021.

Key facts

This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 May 2021, 07:49.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$81,122.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RGEN transaction

Common Stock

Sale

Transaction value: $81,122
Shares: -470
Change %: -1.5%
Price: $172.60
Shares after: 31,893
Date: 14 May 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.

Footnote F2

$172.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.59 to $172.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC remarks

Exhibit 24.1: Power of Attorney